Earnings History Data for Appili Therapeutics (APLIF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Appili Therapeutics
Appili Therapeutics Inc. is a biopharmaceutical company. It acquires, develops and commercializes novel medicines for unmet needs in the infectious disease. The company's lead product consist ATI-2307, ATI-1501 and ATI-1701 which are in clinical stage. Appili Therapeutics Inc. is based in Halifax, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25-06-2024 | AH | APLIF | Appili Therapeutics | 4.00 | -0.01 | -0.01 | 0.00 | 0.0259 | 0.0 (0.98%) |
0.0 | 0.0 (0.00%) |
0.02 - 0.08 | 51,000 | 0 | 0 | |||
|
|
||||||||||||||||||
| 13-02-2024 | PM | APLIF | Appili Therapeutics | 2.00 | N/A | -0.01 | 0.00 | Appili Therapeutics reports Q3 results [2/14/2024 8:37 AM] |
0.0180 | 0.0 (-5.51%) |
0.0 | 0.0 (0.00%) |
0.02 - 0.08 | 164,000 | 0 | 0 | ||
| 13-11-2023 | AH | APLIF | Appili Therapeutics | 3.00 | -0.01 | -0.01 | 0.00 | Appili Therapeutics GAAP EPS of -C$0.01 [11/14/2023 10:41 AM] |
0.0240 | 0.0 (-14.29%) |
0.0 | 0.0 (0.00%) |
0.02 - 0.08 | 87,000 | 0 | 0 | ||
| 11-08-2023 | AH | APLIF | Appili Therapeutics | 5.00 | -0.01 | -0.02 | 0.00 | Appili Therapeutics GAAP EPS of -C$0.01 [8/11/2023 5:45 PM] |
0.04 | 0.0 (8.11%) |
0.0 | 0.0 (0.00%) |
0.02 - 0.08 | 213,935 | 0 | 0 | ||
|
|
||||||||||||||||||
| 14-02-2023 | PM | APLIF | Appili Therapeutics | 5.00 | -0.02 | -0.02 | 0.00 | Appili Therapeutics GAAP EPS of -$0.06 [2/14/2023 9:24 AM] |
0.0419 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.03 - 0.13 | 10 | 0 | 0 | ||
| 12-08-2022 | AH | APLIF | Appili Therapeutics | 4.00 | -0.02 | -0.02 | 0.00 | Appili Therapeutics GAAP EPS of -$0.03 misses by $0.01 [8/12/2022 5:01 PM] |
0.0616 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.05 - 0.90 | 14,481 | 0 | 0 | ||
|
|
||||||||||||||||||
| 14-02-2022 | AH | APLIF | Appili Therapeutics | 7.00 | -0.04 | -0.07 | 0.00 | Appili Therapeutics GAAP EPS of -C$0.05, revenue of C$1.4M [2/14/2022 5:45 PM] |
0.0967 | 0.0 (4.33%) |
0.0 | 0.0 (0.00%) |
0.07 - 1.30 | 11,161 | 0 | 0 | ||
| 12-11-2021 | AH | APLIF | Appili Therapeutics | 37.00 | -0.14 | -0.07 | 0.00 | 0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |||
|
|
||||||||||||||||||
| 13-08-2021 | PM | APLIF | Appili Therapeutics Inc. | 37.00 | -0.10 | -0.06 | 0.00 | Appili Therapeutics reports Q1 results [8/13/2021 7:27 AM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | ||